Thermo Fisher Scientific Inc. (TMO) has a consensus analyst rating of Buy, based on 42 analysts covering the stock. Of those, 38 recommend buying, 4 recommend holding, and 0 recommend selling.
The analyst consensus price target for TMO is $650.58, representing a +23.4% upside from the current price of $527.22. Price targets range from a low of $575.00 to a high of $750.00.